Biomedicines (Oct 2022)

Prior Cancer Is Associated with Lower Atherosclerotic Cardiovascular Disease Risk at First Acute Myocardial Infarction

  • Chieh Yang Koo,
  • Huili Zheng,
  • Li Ling Tan,
  • Ling-Li Foo,
  • Derek J. Hausenloy,
  • Wee-Joo Chng,
  • Soo Chin Lee,
  • Arthur Mark Richards,
  • Lieng-Hsi Ling,
  • Shir Lynn Lim,
  • Chi-Hang Lee,
  • Mark Y. Chan

DOI
https://doi.org/10.3390/biomedicines10112681
Journal volume & issue
Vol. 10, no. 11
p. 2681

Abstract

Read online

Background: Patients with cancer are at increased risk of acute myocardial infarction (AMI). It is unclear if the Atherosclerotic Cardiovascular Disease (ASCVD) risk score at incident AMI is reflective of this higher risk in patients with prior cancer than those without. Methods: We linked nationwide AMI and cancer registries from 2008 to 2019. A total of 18,200 eligible patients with ASCVD risk score calculated at incident AMI were identified (1086 prior cancer; 17,114 no cancer). Results: At incident AMI, age-standardized mean ASCVD risk was lower in the prior cancer group (18.6%) than no cancer group (20.9%) (p < 0.001). Prior to incident AMI, smoking, hypertension, hyperlipidemia and diabetes mellitus were better controlled in the prior cancer group. However post-AMI, prior cancer was associated with lower guideline-directed medical therapy usage and higher all-cause mortality (adjusted hazard ratio 1.85, 95% confidence interval 1.66–2.07). Conclusions: AMI occurred despite better control of cardiovascular risk factors and lower age-standardized estimated mean 10-year ASCVD risk among patients with prior cancer than no cancer. Prior cancer was associated with lower guideline-directed medical therapy post-AMI and higher mortality.

Keywords